©The Author(s) 2017.
World J Gastroenterol. Jul 21, 2017; 23(27): 4958-4967
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4958
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4958
Table 5 Univariable logistic regression data regarding factors associated with anti-tumor necrosis factor treatment failure
| Covariate | P value |
| Demographic variables | |
| Gender | NS |
| Race | NS |
| Montreal Classification | |
| Age of onset (A) Montreal | NS |
| Location (L) Montreal | NS |
| Location (L4) upper GI Montreal | NS |
| Behavior (B) Montreal | 0.131 |
| Behavior (p) perianal Montreal | 0.091 |
| SNP variables | |
| ATG16L1 rs10210302 | NS |
| ATG16L1 rs2241880 | NS |
| FAS Ligand rs763110 | 0.0571 |
| FAS Ligand rs763110 (TC + TT grouped) | 0.021 |
| IBD5 rs2522057 | NS |
| FCGR 3A rs396991 | NS |
| TNF gene (-308) rs1800629 | 0.131 |
| TNF gene (-308) rs1800629 (AA + GA grouped) | 0.0991 |
| TNF gene(-238) rs361525 | NS |
- Citation: Netz U, Carter JV, Eichenberger MR, Dryden GW, Pan J, Rai SN, Galandiuk S. Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn’s disease. World J Gastroenterol 2017; 23(27): 4958-4967
- URL: https://www.wjgnet.com/1007-9327/full/v23/i27/4958.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i27.4958